National Bank of Canada
GRNA

National Bank of Canada’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

National Bank of Canada’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-800
Closed -$928 – 2913
2022
Q4 		$928 Hold
800
– – ﹤0.01% 2592
2022
Q3 		$2K Hold
800
– – ﹤0.01% 2560
2022
Q2 		$2K Buy
+800
New +$5.55K ﹤0.01% 2657

Other funds holding GRNA

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CGC
Continental Grain Company New York $448M AUM 6.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

National Bank of Canada's GRNA Position: Q1 2023 in Review

National Bank of Canada sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q1 2023, closing a stake of 800 shares — an estimated $928 sold.

National Bank of Canada first reported a position in GRNA in Q2 2022 and held it in 3 quarters. The position peaked at $2K in Q3 2022. 60 funds tracked by Wall St. Rank hold GRNA as of Q1 2023.

  • National Bank of Canada reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q1 2023 after selling out during the quarter.
  • National Bank of Canada sold 800 GreenLight Biosciences Holdings, PBC Common Stock shares in Q1 2023, an estimated $928.
  • National Bank of Canada first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q2 2022 and held it in 3 quarters.
  • National Bank of Canada's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $2K in Q3 2022.
  • 60 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q1 2023.

Based on National Bank of Canada's 13F filing for Q1 2023, filed 12 Apr 2023.